Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean G Rudd

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Iscience|February 6, 2024
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelSi Min Zhang, Cynthia B J Paulin, Huazhang Shu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase FunctionMario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Nature Chemical Biology|July 22, 2020
Development of a chemical probe against NUDT15Si Min Zhang, Matthieu Desroses, Anna Hagenkort, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|January 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Nature Communications|November 3, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cellsBrent D G Page, Nicholas C K Valerie, Roni H G Wright, et al.
Iscience|February 6, 2024
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelSi Min Zhang, Cynthia B J Paulin, Huazhang Shu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2025
Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase FunctionMario Kehler, Kaixin Zhou, Aurino M Kemas, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Nature Chemical Biology|July 22, 2020
Development of a chemical probe against NUDT15Si Min Zhang, Matthieu Desroses, Anna Hagenkort, et al.
International Journal of Molecular Sciences|February 27, 2026
Antisense Dipeptide Repeat Proteins Drive Widescale Purine Metabolism Aberration in <i>C9orf72</i> Amyotrophic Lateral Sclerosis via ADABenjamin Hall, Lydia Castelli, Adrian Higginbottom, et al.
Pageof 4